Glassman Wealth Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Glassman Wealth Services’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,382	Closed	-$68.5K	–	194
2024 Q1	$68.5K	Hold	2,382	–	–	0.01%	102
2023 Q4	$78.2K	Hold	2,382	–	–	0.01%	344
2023 Q3	$66.4K	Buy	+2,382	New	+$77.9K	0.01%	354
2023 Q1	–	Sell	-3,695	Closed	-$104K	–	1899
2022 Q4	$104K	Buy	3,695 +1,150	+45%	+$36.5K	0.02%	261
2022 Q3	$84K	Hold	2,545	–	–	0.02%	274
2022 Q2	$80K	Hold	2,545	–	–	0.02%	296
2022 Q1	$117K	Buy	+2,545	New	+$121K	0.02%	232
2021 Q4	–	Sell	-1,847	Closed	-$138K	–	1626
2021 Q3	$138K	Hold	1,847	–	–	0.03%	191
2021 Q2	$171K	Buy	1,847 +411	+29%	+$34.9K	0.04%	160
2021 Q1	$127K	Buy	1,436 +805	+128%	+$79.8K	0.03%	194
2020 Q4	$59K	Hold	631	–	–	0.01%	311
2020 Q3	$40K	Hold	631	–	–	0.01%	334
2020 Q2	$33K	Hold	631	–	–	0.01%	310
2020 Q1	$20K	Buy	631 +20	+3%	+$668	0.01%	339
2019 Q4	$21K	Sell	611 -1	-0.2%	-$32	0.01%	367
2019 Q3	$18K	Hold	612	–	–	0.01%	364
2019 Q2	$21K	Hold	612	–	–	0.01%	358
2019 Q1	$20K	Buy	612 +12	+2%	+$354	0.01%	352
2018 Q4	$14K	Hold	600	–	–	0.01%	332
2018 Q3	$20K	Buy	+600	New	+$19K	0.01%	324

Other funds holding ARKG

MMEA

Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Glassman Wealth Services's ARKG Position: Q2 2024 in Review

Glassman Wealth Services sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 2,382 shares — an estimated $68.5K sold.

Glassman Wealth Services first reported a position in ARKG in Q3 2018 and held it in 20 quarters. The position peaked at $171K in Q2 2021. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

Glassman Wealth Services reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
Glassman Wealth Services sold 2,382 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $68.5K.
Glassman Wealth Services first reported a position in ARK Genomic Revolution ETF in Q3 2018 and held it in 20 quarters.
Glassman Wealth Services's ARK Genomic Revolution ETF position peaked at $171K in Q2 2021.
261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on Glassman Wealth Services's 13F filing for Q2 2024, filed 6 Aug 2024.